Discovery and characterization of the N-phenyl-N'-naphthylurea class of p38 kinase inhibitors.
Cirillo, P.F., Hickey, E.R., Moss, N., Breitfelder, S., Betageri, R., Fadra, T., Gaenzler, F., Gilmore, T., Goldberg, D.R., Kamhi, V., Kirrane, T., Kroe, R.R., Madwed, J., Moriak, M., Netherton, M., Pargellis, C.A., Patel, U.R., Qian, K.C., Sharma, R., Sun, S., Swinamer, A., Torcellini, C., Takahashi, H., Tsang, M., Xiong, Z.(2009) Bioorg Med Chem Lett 19: 2386-2391
- PubMed: 19356929 
- DOI: https://doi.org/10.1016/j.bmcl.2009.03.104
- Primary Citation of Related Structures:  
3GI3 - PubMed Abstract: 
An effort aimed at exploring structural diversity in the N-pyrazole-N'-naphthylurea class of p38 kinase inhibitors led to the synthesis and characterization of N-phenyl-N'-naphthylureas. Examples of these compounds displayed excellent inhibition of TNF-alpha production in vitro, as well as efficacy in a mouse model of lipopolysaccharide induced endotoxemia. In addition, perspective is provided on the role of a sulfonamide functionality in defining inhibitor potency.
Organizational Affiliation: 
Department of Medicinal Chemistry, Boehringer Ingelheim Pharmaceutical, Inc., 900 Ridgebury Road, Ridgefield, CT 06877, USA.